BACKGROUND: Listeriosis is a foodborne disease of significant public health concern that primarily affects persons with recognized underlying conditions or diseases that impair cell-mediated immunity. The degree of risk posed by the different underlying conditions is crucial to prioritize prevention programs that target the highest risk populations. METHODS: We reviewed cases of listeriosis reported in France from 2001 to 2008. Numbers of cases and deaths were tabulated by age and underlying condition. Measures of the impact of specific underlying conditions on the occurrence of listeriosis were calculated. For estimating the total number of persons living with specific diseases, we applied prevalence estimates of these diseases to the French population. Underlying conditions were ranked by the degree to which they increased the risk of listeriosis. RESULTS: From 2001 to 2008, 1959 cases of listeriosis were reported in France (mean annual incidence 0.39 per 100,000 residents). Compared with persons <65 years with no underlying conditions, those with chronic lymphocytic leukemia had a >1000-fold increased risk of acquiring listeriosis, and those with liver cancer; myeoloproliferative disorder; multiple myeloma; acute leukemia; giant cell arteritis; dialysis; esophageal, stomach, pancreas, lung, and brain cancer; cirrhosis; organ transplantation; and pregnancy had a 100-1000-fold increased risk of listeriosis. CONCLUSIONS: To be effective and acceptable to physicians and patients, listeriosis prevention strategies should be targeted based on evidence of increased risk. Stringent dietary guidance, to avoid specific foods with a high risk for Listeria contamination, should be targeted to pregnant women and to others at highest risk of listeriosis.
BACKGROUND: Listeriosis is a foodborne disease of significant public health concern that primarily affects persons with recognized underlying conditions or diseases that impair cell-mediated immunity. The degree of risk posed by the different underlying conditions is crucial to prioritize prevention programs that target the highest risk populations. METHODS: We reviewed cases of listeriosis reported in France from 2001 to 2008. Numbers of cases and deaths were tabulated by age and underlying condition. Measures of the impact of specific underlying conditions on the occurrence of listeriosis were calculated. For estimating the total number of persons living with specific diseases, we applied prevalence estimates of these diseases to the French population. Underlying conditions were ranked by the degree to which they increased the risk of listeriosis. RESULTS: From 2001 to 2008, 1959 cases of listeriosis were reported in France (mean annual incidence 0.39 per 100,000 residents). Compared with persons <65 years with no underlying conditions, those with chronic lymphocytic leukemia had a >1000-fold increased risk of acquiring listeriosis, and those with liver cancer; myeoloproliferative disorder; multiple myeloma; acute leukemia; giant cell arteritis; dialysis; esophageal, stomach, pancreas, lung, and brain cancer; cirrhosis; organ transplantation; and pregnancy had a 100-1000-fold increased risk of listeriosis. CONCLUSIONS: To be effective and acceptable to physicians and patients, listeriosis prevention strategies should be targeted based on evidence of increased risk. Stringent dietary guidance, to avoid specific foods with a high risk for Listeria contamination, should be targeted to pregnant women and to others at highest risk of listeriosis.
Authors: Annukka Markkula; Miia Lindström; Per Johansson; Johanna Björkroth; Hannu Korkeala Journal: Appl Environ Microbiol Date: 2012-07-20 Impact factor: 4.792
Authors: James A West; Anthony R Onofrio; Lauren C Martinez; Michael J Opatowsky; Cedric W Spak; Kennith F Layton Journal: Proc (Bayl Univ Med Cent) Date: 2015-07
Authors: Lisa M Rogers; Tennille Thelen; Krystle Fordyce; Emilie Bourdonnay; Casey Lewis; Han Yu; Junyong Zhang; Jingli Xie; Carlos H Serezani; Marc Peters-Golden; David M Aronoff Journal: Am J Reprod Immunol Date: 2013-08-01 Impact factor: 3.886
Authors: Juno Thomas; Nevashan Govender; Kerrigan M McCarthy; Linda K Erasmus; Timothy J Doyle; Mushal Allam; Arshad Ismail; Ntsieni Ramalwa; Phuti Sekwadi; Genevie Ntshoe; Andronica Shonhiwa; Vivien Essel; Nomsa Tau; Shannon Smouse; Hlengiwe M Ngomane; Bolele Disenyeng; Nicola A Page; Nelesh P Govender; Adriano G Duse; Rob Stewart; Teena Thomas; Deon Mahoney; Mathieu Tourdjman; Olivier Disson; Pierre Thouvenot; Mylène M Maury; Alexandre Leclercq; Marc Lecuit; Anthony M Smith; Lucille H Blumberg Journal: N Engl J Med Date: 2020-02-13 Impact factor: 91.245
Authors: Elyara M Soares; Katie L Mason; Lisa M Rogers; Carlos H Serezani; Lucia H Faccioli; David M Aronoff Journal: J Immunol Date: 2013-01-16 Impact factor: 5.422